Biotech · Public company · Miami, FL, US
Veru Inc.
Ticker VERU · SEC CIK 0000863894
Track this companyFree. Adds Veru Inc. to your Dealase workspace and tells you when its record changes.
Clinical trials111 recruiting or active
Pipeline programs16From trials and the company's site
Disclosed deals0None found yet
Cash runwayNot availableNo recent cash burn filed
Pipeline16
- EnobosarmPhase 3 · Metastatic Breast CancerClinicalTrials.gov · fetched Nov 12, 2026
- Enobosarm & Abemaciclib ComboPhase 3 · Metastatic Breast CancerClinicalTrials.gov · fetched Nov 12, 2026
- Enzalutamide, AbirateronePhase 3 · Metastatic Castration-resistant Prostate CancerClinicalTrials.gov · fetched Nov 12, 2026
- ExemestanePhase 3 · Metastatic Breast CancerClinicalTrials.gov · fetched Nov 12, 2026
- non-steroidal AI, or steroidal AI (exemestane with or without everolimus) or FulvestrantPhase 3 · Metastatic Breast CancerClinicalTrials.gov · fetched Nov 12, 2026
- VERU-111Phase 3 · Metastatic Castration-resistant Prostate CancerClinicalTrials.gov · fetched Nov 12, 2026
- VERU-111Phase 3 · SARS-CoV InfectionClinicalTrials.gov · fetched Nov 12, 2026
- EnobosarmPhase 2 · Obesity & OverweightClinicalTrials.gov · fetched Nov 12, 2026
- EnobosarmPhase 2 · Muscle LossClinicalTrials.gov · fetched Nov 12, 2026
- Exemestane monotherapy, exemestane plus everolimus, or selective estrogen receptor modulatorPhase 2 · Metastatic Breast CancerClinicalTrials.gov · fetched Nov 12, 2026
- SabizabulinPhase 2 · Metastatic Breast CancerClinicalTrials.gov · fetched Nov 12, 2026
- SemaglutidePhase 2 · Muscle LossClinicalTrials.gov · fetched Nov 12, 2026
- Semaglutide (Wegovy) weekly injectionPhase 2 · Obesity & OverweightClinicalTrials.gov · fetched Nov 12, 2026
- VERU-100Phase 2 · Advanced Prostate AdenocarcinomaClinicalTrials.gov · fetched Nov 12, 2026
- Veru-111Phase 2 · Respiratory Distress Syndrome, AdultClinicalTrials.gov · fetched Nov 12, 2026
- Veru-944Phase 2 · Prostate Cancer MetastaticClinicalTrials.gov · fetched Nov 12, 2026
Clinical trials11
- Proof-of-Concept Study Evaluating Total Body Weight, Physical Function & Safety of Enobosarm in Patients Treated With GLP-1 Receptor Agonist, for Weight LossPHASE2 · ACTIVE_NOT_RECRUITING · started Mar 26, 2026ClinicalTrials.gov NCT07446998 · fetched Nov 12, 2026
- Dose-Finding Study Evaluating Effect on Body Composition of Enobosarm in Patients Taking a GLP-1 for Chronic Weight MgmtPHASE2 · COMPLETED · started Apr 29, 2024ClinicalTrials.gov NCT06282458 · fetched Nov 12, 2026
- Efficacy Evaluation of Sabizabulin Monotherapy Versus Active Control for Treatment of ER+HER2- Metastatic Breast CancerPHASE2 · WITHDRAWN · started Mar 15, 2023ClinicalTrials.gov NCT05079360 · fetched Nov 12, 2026
- Efficacy & Safety Evaluation of Enobosarm in Combo With Abemaciclib in Treatment of ER+HER2- Metastatic Breast CancerPHASE3 · TERMINATED · started Apr 11, 2022ClinicalTrials.gov NCT05065411 · fetched Nov 12, 2026
- Efficacy Evaluation of Enobosarm Monotherapy in Treatment of AR+/ER+/HER2- Metastatic Breast CancerPHASE3 · TERMINATED · started Oct 12, 2021ClinicalTrials.gov NCT04869943 · fetched Nov 12, 2026
- Efficacy Evaluation of VERU-111 for mCRPC in Patients Who Have Failed at Least One Androgen Receptor Targeting AgentPHASE3 · TERMINATED · started Jun 24, 2021ClinicalTrials.gov NCT04844749 · fetched Nov 12, 2026
- To Determine an Effective Dose of VERU-100 for the Treatment of Advanced Prostate CancerPHASE1_PHASE2 · TERMINATED · started Jun 9, 2021ClinicalTrials.gov NCT04843319 · fetched Nov 12, 2026
- VERU-111 in the Treatment of SARS-Cov-2 Infection by Assessing Its Effect on the Proportion of Patients Who Die on StudyPHASE3 · COMPLETED · started May 18, 2021ClinicalTrials.gov NCT04842747 · fetched Nov 12, 2026
- COVID-19 Treatment of Severe Acute Respiratory Syndrome With Veru-111PHASE2 · COMPLETED · started Jun 18, 2020ClinicalTrials.gov NCT04388826 · fetched Nov 12, 2026
- To Evaluate Safety and Tolerability of VERU-111 in Men With Advanced Metastatic Castration Resistant Prostate CancerPHASE1_PHASE2 · TERMINATED · started Jan 18, 2019ClinicalTrials.gov NCT03752099 · fetched Nov 12, 2026
- Study of VERU-944 to Ameliorate Hot Flashes in Men With Advanced Prostate CancerPHASE2 · COMPLETED · started Sep 14, 2018ClinicalTrials.gov NCT03646162 · fetched Nov 12, 2026
SEC filings12
- 8-K · 8-KSEC EDGAR · filed Sep 8, 2026 · fetched Nov 12, 2026
- 10-Q · FORM 10-QSEC EDGAR · filed Aug 10, 2026 · fetched Nov 12, 2026
- 8-K · 8-KSEC EDGAR · filed Aug 10, 2026 · fetched Nov 12, 2026
- 8-K · 8-KSEC EDGAR · filed Jul 2, 2026 · fetched Nov 12, 2026
- 8-K · FORM 8-KSEC EDGAR · filed Jun 4, 2026 · fetched Nov 12, 2026
- 10-Q · FORM 10-QSEC EDGAR · filed May 13, 2026 · fetched Nov 12, 2026
- 8-K · 8-KSEC EDGAR · filed May 13, 2026 · fetched Nov 12, 2026
- 8-K · FORM 8-KSEC EDGAR · filed Mar 13, 2026 · fetched Nov 12, 2026
- 10-Q · FORM 10-QSEC EDGAR · filed Feb 11, 2026 · fetched Nov 12, 2026
- 8-K · 8-KSEC EDGAR · filed Feb 11, 2026 · fetched Nov 12, 2026
- 10-K · FORM 10-KSEC EDGAR · filed Dec 17, 2025 · fetched Nov 12, 2026
- 8-K · 8-KSEC EDGAR · filed Dec 17, 2025 · fetched Nov 12, 2026